Atlas Trials

Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with CKD

Clinical trial NCT05359263 · RECRUITING

Trial details

NCT number
NCT05359263
Sponsor
Tor Biering-Sørensen
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Kidney Diseases
Start date
2022-06-08
Primary completion
2025-02-18
Enrollment
222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.